Dr Madelon De Jong

Dr Madelon De Jong

Dr Madelon De Jong

Research Fellow (Immunology & Infection), University of Oxford

ORCiD: 0000-0002-6145-6154

Dr Madelon de Jong is an immunologist and medical doctor at the Kennedy Institute of Rheumatology at the University of Oxford. 

Dr de Jong completed her medical and scientific training in the Netherlands, where she developed a strong interest in combining patient-focused research with laboratory science. During her PhD, she studied how inflammation changes the bone marrow and immune system in blood cancers, which sparked a broader interest in chronic inflammatory diseases such as rheumatoid arthritis. Her current research focuses on how changes in blood cell production contribute to autoimmune disease, with the aim of identifying new therapeutic opportunities. 

Areas of professional expertise

  • Arthritis UK Career Development Fellow and clinician-scientist at the Kennedy Institute of Rheumatology
  • Leads a research programme on bone marrow changes in autoimmune disease
  • Focuses on how changes in blood cell production contribute to autoimmune disease, with the aim of identifying new therapeutic opportunities.

Qualifications and credentials

  • Trained in Medicine (MD) and Infection & Immunity (MSc) at Erasmus University Rotterdam
  • PhD from the Erasmus MC Cancer Institute

Arthritis UK research projects

Rheumatoid arthritis - The role of bone marrow in rheumatoid arthritis | Arthritis UK, Arthritis UK, 2026 - 2031

What is your fellowship project aiming to do?

This research aims to understand whether joint inflammation changes the way bone marrow produces immune cells, particularly ones likely to drive future flares. 

Why is your research important?

Although treatments for rheumatoid arthritis have improved enormously, many people still experience repeated flares and progressive joint damage over time. This research will investigate whether inflammation leaves behind longer-lasting changes in the immune system that make flares more likely. If we can better understand these changes, we may eventually be able to prevent flares before they happen, rather than only reacting once symptoms appear. 

In the long term, this research will help us better understand the root causes of chronic inflammation in rheumatoid arthritis, rather than only treating its symptoms. 

What will the impact be for people with arthritis/MSK disorders?

Early research suggests that bone marrow becomes inflamed during arthritis. The research also found that bone marrow may stay inflamed even after arthritis symptoms have improved. This suggests that bone marrow may hold on to a “memory” of inflammation. If this is true, it could help explain why some flare-ups happen again and why they may be severe. 

The next step is to build a clearer picture of how bone marrow changes in rheumatoid arthritis. If the research shows that bone marrow plays an important role, it could open the door to new treatments that target the disease in a different way. The long-term hope is to help people have fewer flare-ups, less pain and better health over time.